Harmony Biosciences Holdings, Inc. (HRMY)
Automate Your Wheel Strategy on HRMY
With Tiblio's Option Bot, you can configure your own wheel strategy including HRMY - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol HRMY
- Rev/Share 13.4423
- Book/Share 13.4519
- PB 1.9767
- Debt/Equity 0.2226
- CurrentRatio 3.838
- ROIC 0.2125
- MktCap 1529791861.0
- FreeCF/Share 4.502
- PFCF 5.9127
- PE 8.4471
- Debt/Assets 0.1553
- DivYield 0
- ROE 0.2632
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 3
- DCF Score 1
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | HRMY | Truist | -- | Buy | -- | $48 | July 21, 2025 |
| Resumed | HRMY | Goldman | -- | Neutral | -- | $33 | July 10, 2025 |
| Resumed | HRMY | Oppenheimer | -- | Outperform | -- | $61 | June 2, 2025 |
| Initiation | HRMY | Deutsche Bank | -- | Buy | -- | $55 | Feb. 11, 2025 |
| Initiation | HRMY | H.C. Wainwright | -- | Buy | -- | $75 | Dec. 17, 2024 |
| Resumed | HRMY | Raymond James | -- | Outperform | -- | -- | Oct. 10, 2024 |
| Initiation | HRMY | UBS | -- | Buy | -- | $56 | Sept. 10, 2024 |
News
Harmony Biosciences (HRMY) Upgraded to Strong Buy: Here's Why
Published: February 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Harmony Biosciences (HRMY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder
Published: February 19, 2025 by: Benzinga
Sentiment: Negative
On Wednesday, Harmony Biosciences Holdings, Inc. HRMY received a Refusal to File (RTF) letter from the U.S. Food and Drug Administration (FDA) for pitolisant for excessive daytime sleepiness (EDS) in adult patients with idiopathic hypersomnia (IH).
Read More
HRMY or ONC: Which Is the Better Value Stock Right Now?
Published: February 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Harmony Biosciences Holdings, Inc. (HRMY) and BeiGene, Ltd. (ONC). But which of these two stocks is more attractive to value investors?
Read More
Here is Why Growth Investors Should Buy Harmony Biosciences (HRMY) Now
Published: February 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Harmony Biosciences (HRMY) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
About Harmony Biosciences Holdings, Inc. (HRMY)
- IPO Date 2020-08-19
- Website https://www.harmonybiosciences.com
- Industry Biotechnology
- CEO Jeffrey M. Dayno
- Employees 268